Clinical Trial Update: QoL and Adherence to One-pill Once-a-day HAART [Phase 3]

View source ↗

Summary

Phase 3 trial update focusing on quality of life and adherence for a one-pill, once-daily HAART regimen in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: HIV Infection, HIV Infections | Phase 3 | Status: COMPLETED